Key Releases are ad hoc announcements pursuant to SIX Swiss Exchange Article 53 Listing Rules.
Header
News Archive
Showing 108 results
January 2020
-
Featured News
Novartis at the World Economic Forum Annual Meeting Davos 2020
From January 21-24 2020, Novartis attended the World Economic Forum Annual Meeting in Davos, Switzerland.
-
Featured News
Novartis at J.P Morgan 2020
From January 13-16 2020, Novartis attended the J.P Morgan Healthcare Conference in San Francisco.
December 2019
-
Featured News
Uncovering profound and under-reported effects on people living with sickle cell disease
Results of the Sickle Cell World Assessment Survey (SWAY) highlight the impact this debilitating disease has on patients and their families.
-
Featured News
Novartis R&D Day
Novartis shares progress in advancing its industry-leading R&D pipeline. We are uniquely positioned to deliver transformational treatments through our scale, focus on innovative medicines, diverse range of therapeutic areas and exposure to cutting-edge platforms.
-
Featured News
Amazon Web Services (AWS) announces strategic collaboration with Novartis to accelerate digital transformation of its business operations
-
Featured News
Behind the research driving our data at medical conferences
Novartis data at 2019 ASH and SABCS underscore our evolving R&D approach in innovative platforms to reimagine medicine and help improve patient outcomes.
November 2019
October 2019
-
Featured News
Pride @ Novartis 2019
As a company, we stand up for greater inclusion of LGBTI people because when each of us feels included, we all benefit.
-
Featured News
World Sight Day 2019
-
Featured News
Novartis and Microsoft announce collaboration to transform medicine with artificial intelligence